Suprenza was developed by Citius Pharmaceuticals, Inc. and approved by the FDA in 2011. As an orally disintegrating tablet (ODT), the pill was a true innovation in the world of phentermine diet pills. However, in 2016 Citius Pharmaceuticals, Inc. elected to discontinue Suprenza and devote the company’s resources to other products.
It was officially removed from the US market on September 30, 2018.
Suprenza® was a peppermint-flavored orally disintegrating tablet that dissolved on your tongue. Because it dissolved on your tongue easily and could be taken without water, it was more convenient than other phentermine tablets and capsules. It could be taken at any time: before, during or after your meal.
Suprenza was sold in two different doses: 15mg and 30mg.
|15 mg||Round, yellow tablets with blue spots||AX4 on one side||NDC: 24090 720|
|30 mg||Round, yellow tablets||AX7 on one side||NDC: 24090 721|
Suprenza 15mg and 30mg ODTs were packaged in bottles of either 30 or 100 tablets.
Suprenza was an appetite suppressant prescribed for obese patients, as well as overweight patients who with weight-related conditions such as such as diabetes, high blood pressure or high cholesterol.
To qualify as a suitable candidate for Suprenza, a patient needed a BMI of 27 or greater.
Suprenza was an appetite suppressant, and like all phentermine diet pills, it worked by activating the central nervous system and suppressing hunger. It also increased energy, which could be expended through exercise.
Suprenza was designed to be used in combination with a healthy diet and regular exercise. Since phentermine can be habit forming, Suprenza could only be prescribed for a short period of time. Changing eating habits and exercise routine were essential to maintaining the weight loss results.
Phentermine, the active ingredient in Suprenza, is a Class IV controlled substance in the US, so this medication was only available with a doctor's prescription. Suprenza was never available outside of the United States.
Potential side effects of Suprenza included:
If you or someone you know experiences any of the bolded reactions while taking phentermine, call emergency medical services or get to a hospital right away.
Daily dosage should be individualized to acheive the best response with the lowest possible dose. With Suprenza, the physician was responsible for defining the most appropriate dose for each patient.
Nonetheless, the usual dose was one tablet per day taken in the morning with or without food.
Suprenza was an orally disintegrating tablet, so administration instructions were as follows:
In discussing Suprenza, or any other brand of phentermine weight loss pills, it is critical to inform your doctor:
Suprenza should be prescribed in the lowest effective dose to minimize the risk of overdose. An overdose of phentermine can have serious consequences. If quantities are high enough, this can include death.
If an overdose is suspected seek medical help immediately.
Symptoms of phentermine overdose can include: restlessness, tremor, hyperreflexia, rapid respiration, confusion, aggression, hallucinations, panic states, fatigue, depression, arrhythmia, hypertension or hypotension, circulatory collapse, nausea, vomiting, diarrhea and/or abdominal cramps.
Suprenza was undoubtedly convenient, but did it actually help people lose weight? This medication generally worked well, but patients complained that it tasted bad and cost significantly more than other preparations of phentermine HCL.
Here are a few real users' reviews of Suprenza:
Curious about other brands of phentermine?
Click here to browse hundreds more phentermine reviews, sorted by brand, recency and overall rating.
Suprenza® was manufactured in Switzerland by Alpex Pharma SA. It was marketed and distributed in the US by Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc.
11 Commerce Drive, First Floor
Cranford, NJ 07016
Phone: (908) 967-6677
Corporate web site: https://www.citiuspharma.com/